Jim Cornall
Base to Base Biotech
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world. Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed. The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall. Base to Base is an Ayr Coastal Media Ltd production.
Be sure to visit the podcast's website and support the creator: www.deeptechdigest.com
Author
Jim Cornall
Category
Podcast website
Latest episode
Nov 20, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer 23.05.2025 42:47
This week, we have a conversation with Vidmantas Šakalys, CEO of bioprinting company Vital3D Technologies, and a chat with Oriana Papin-Zoghbi, CEO and co-founder of AOA Dx, another of the companies that attended the American Association for Cancer Research (AACR) annual meeting in Chicago recently. Interview times: 01:47 Vital3D Technologies 20:46 AOA Dx Vital3D Technologies Lithuanian company Vi...
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR 16.05.2025 1:08:38
This week, we’re talking to some of the companies that attended the American Association for Cancer Research (AACR) annual meeting in Chicago. We have interviews with Microbiotica, 1Cell. Ai, and Tessellate Bio. Interview times: 01:55 Tessellate Bio 17:02 1Cell. Ai (formerlyOneCell Diagnostics) 44:04 Microbiotica Microbiotica Mat Robinson, SVP Research at Microbiotica , is one of our guests. Micro...
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations 09.05.2025 43:10
This week on the podcast, we have a conversation with Elise de Reus, the co-founder of Cradle, a biotech startup that is revolutionising protein design, and a chat about improving hospital operations with Proximie’s CEO and founder, plastic surgeon Dr. Nadine Hachach-Haram. Interview times: 01:55 Proximie 21:40 Cradle Proximie Proximie has built the only cloud OS for intelligent operating rooms. W...
Base to Base biotech podcast 7: The DSCSA deadline and MoonLake's Nanobody 02.05.2025 47:39
This week on the podcast, we have a conversation with Tim Tinnel, executive vice president/chief operating officer of Intelliguard, talking about – among other things – the looming Drug Supply Chain Security Act (DSCSA) deadline, and Jorge Jorge Santos da Silva, founder and CEO of MoonLake Immunotherapeutics, about its Nanobody programme. Interview times: 01:42 MoonLake Immunotherapeutics 25:24 In...
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme 25.04.2025 34:10
This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, about treating chronic low back pain, and with Monika Paulė, CEO and co-founder of Caszyme. Interview time stamps: Times: 01:40 Caszyme 16:04 Persica Pharmaceuticals Persica Pharmaceuticals Persica is developing a potentially transformative non-opioid treatment for chronic low back pain (cLBP) with...
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims 18.04.2025 54:26
This week on the podcast, we have a conversation with Vitalant’s Kevin Land, executive medical director, Biotherapies, and VP of Clinical Services, and Becky Cap, SVP, Biotherapies; and chat with Brainomix CEO and co-founder Michalis Papadakis about making a difference in getting faster treatments for stroke victims. Times: 01:52 Brainomix 21:44 Vitalant Vitalant Vitalant , which used to be known...
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025 11.04.2025 50:52
This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, and about a potential new class of synthetic therapeutics. Interview times: 02:49 ThirdLaw Molecular 21:14 Occam Global ThirdLaw Molecular ThirdLaw Molecular is a biotech company that has pioneered the discovery and development of Spiroligomer molecules – a groundbreaking new platform for targeted dr...
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy 04.04.2025 52:29
Interview timestamps: 02:20 Satellos 26:00 EVŌQ Nano Antibiotic-resistant infections are a top 10 global health threat demanding urgent innovation. A US-based nanotech company, EVŌQ Nano , has developed a novel nanoparticle that destroys bacteria from the inside – without triggering antimicrobial resistance (AMR). The nanoparticle is already in development for an inhaled therapeutic for Cystic Fib...
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics 28.03.2025 48:31
Our guest, Dr. Hernan Bazan, is the CEO and co-founder of South Rampart Pharma . He is also a board-certified vascular surgeon. Bazan is also the recipient of the 2024 NIH HEAL (Helping to End Addiction Long-term) Director's Trailblazer Award for his work in developing a non-addictive pain medication as an alternative to opioids. At South Rampart Pharma, he is leading the development of SRP-001, a...
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics 21.03.2025 44:03
Osteoboost Health Inc. just announced its sixth U.S. patent for its wearable device that uses vibration therapy to strengthen bones and help women live stronger, longer lives. The company is tackling acritical health challenge: osteopenia, a condition affecting millions of women worldwide. Osteoboost is the first and only FDA-cleared, non-drug prescription treatment for low bone density. Powered b...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.